Międzynarodowe nagrody za działalność naukową dla członków zespołu Zakładu Medycyny Nuklearnej:
- #SoMe Award by European Urology Oncology for the article “[68Ga]Ga-PSMA Versus [18F]PSMA Positron Emission Tomography/Computed Tomography in the Staging of Primary and Recurrent Prostate Cancer. A Systematic Review” 2022
- Award of "World Association of Radiopharmaceutical and Molecular Therapy" (WARMTH) – Nanjin for the work “Targeted alpha therapy of recurrent glia tumors: clinical experience with 225Ac-Substance P” 2019.
- Gold prize for Hisada Award (the best paper award).” "Long-term results and tolerability of tandem peptide receptor radionuclide therapy with 90Y/177Lu-DOTATATE in neuroendocrine tumors with respect to the primary location: a 10-year study " 2018
- Marie Curie Award for outstanding scientific work presented at the 29 Annual Congress of the EANM 2016 Barcelona. "Secondary glioblastoma multiforme - local alpha emitters targeted therapy with 213Bi-DOTA-Substance P" 2016
- Nomination to Marie Curie Award- one of the best six abstracts submitted for the EANM congress 2014, Gothenburg- “Alphaknife for glioma tumors: two years experiences with targeted alpha therapy of 213Bi-substance P
- II award “Radioguided surgery in patient with pancreatic neuroendocrine tumour followed by PET/CT scan as a new approach of complete resection evaluation--case report” Congress of Polish Society of Nuclear Medicine, 2016, Bydgoszcz, Poland
- I award as the best poster presentation 11th Congress of the World Federation of Nuclear Medicine and Biology. “213Bi-substance P in targeted alpha therapy of glia tumors“ 2014,Cancun, Mexico
- II award “The Utility of 18FDG PET/CT in differentiation malignant from benign tumors in the adrenal glands” Nuclear Medicine Review Session, Congress of Polish Society of Nuclear Medicine, 2014, Lublin, Poland
- II award „PET/CT examinations with 68Ga-DOTATATE in neuroendocrine tumors - diagnosis of primary tumors”; SGH Nuclear Medicine Update, 02. 2011, Singapur
- I award Society of Nuclear Medicine (SNM) Molecular Imaging Young Investigator Award, “Clinical results of PRRT with 90Y-DOTATATE and 90Y/177Lu-DOTATATE-what is better for therapy?”; 56th Society of Nuclear Medicine (SNM), 2009, Toronto, Canada
- II award Nuclear Oncology Council Young Investigator Award: “Clinical results of PRRT with 90Y-DOTATATE and 90Y/177Lu-DOTATATE -what is better for therapy?”; 56th Society of Nuclear Medicine (SNM) Annual Meeting, 2009, Toronto, Canada
- EANM Eckert & Ziegler Abstract Award 2009 “Comparison between clinical results of PRRT with 90Y-DOTATATE and 90Y/177Lu-DOTATATE” Congress of European Association of Nuclear Medicine (EANM) 2009 Barcelona
- Awards for the best oral presentation ”Results of 90Y-DOTATATE therapy in patients with neuroendocrine tumors - own experience”; Congress 18th International IRIST 2006, Londyn, England